...期 超声观察了84例转移性肝癌在射频消融[1](radiofrequency ablation,RFA)联合瘤内注射无水乙醇(percutaneous ethanol injection,PEI)治疗前后肿瘤内血流的变化,以探讨彩色多普勒超声(CDFI)在RFA+PEI治疗转移性肝癌的临床价值。
基于6个网页-相关网页
...声观察了84例转移性肝癌在射频消融[1](radiofrequency ablation,RFA)联合瘤内注射无水乙醇(percutaneous ethanol injection,PEI)治疗前后肿瘤内血流的变化,以探讨彩色多普勒超声(CDFI)在RFA+PEI治疗转移性肝癌的临床价值。
基于2个网页-相关网页
方法对52例患者的68只甲状腺囊肿在超声定位、引导下用穿刺抽净囊液及囊内注射无水乙醇进行治疗。
Methods the method is to 68 thyroid cysts of 52 patients under the direction of B-ultrasonic scan, drawing liquid from and injecting ethanol into thyroid cysts.
经皮化学灭活介入治疗肝癌主要有经皮无水乙醇瘤内注射(PEIT)和经皮乙酸注射(PAIT)两种。
Chemoablation of the liver cancer include both percutaneous ethanol injection therapy (PEIT) and percutaneous acetic acid injection therapy (PAIT).
目的：分析肝癌患者瘤内无水乙醇注射治疗（PEIT）疗效的影响因素，完善治疗技术。
PURPOSE:To analyze factors that affect percutaneous ethanol injection therapy (PEIT), in order to improve PEIT technology.
应用推荐